Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction? - Contacts and Locations

Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?

This study is currently recruiting participants.

Study NCT00688480. Last updated on July 10, 2008. Information provided by University of Dundee

Please refer to this study by its ClinicalTrials.gov identifier: NCT00688480

Contacts


Contact: Michelle Kao, MBChB, MRCP	44-138-266-0111 ext 33452	m.kao@dundee.ac.uk

Contact: Allan Struthers, MBChB, MRCP, MD, FRCP	44-138-263-2180	a.d.struthers@dundee.ac.uk

Locations


United Kingdom
	Division of Medicine and Therapeutics, Ninewells Hospital & Medical School	Recruiting
	Dundee, United Kingdom, DD1 9SY
	Contact: Michelle Kao 44-138-266-0111 ext 33452 m.kao@dundee.ac.uk

Sponsors and Collaborators

University of Dundee

Investigators


Principal Investigator:	Allan D Struthers, BSc, MD, FRCP, FESC	University of Dundee